4.8 Article

Aberrant AKT activation drives well-differentiated liposarcoma

Related references

Note: Only part of the references are listed.
Review Neurosciences

Mammalian Target of Rapamycin: Its Role in Early Neural Development and in Adult and Aged Brain Function

Carla Garza-Lombo et al.

FRONTIERS IN CELLULAR NEUROSCIENCE (2016)

Article Immunology

Pten mediates Myc oncogene dependence in a conditional zebrafish model of T cell acute lymphoblastic leukemia

Alejandro Gutierrez et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2011)

Article Cell Biology

S6K1 Plays a Critical Role in Early Adipocyte Differentiation

Larissa S. Carnevalli et al.

DEVELOPMENTAL CELL (2010)

Article Genetics & Heredity

Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy

Jordi Barretina et al.

NATURE GENETICS (2010)

Review Biotechnology & Applied Microbiology

Targeting the phosphoinositide 3-kinase pathway in cancer

Pixu Liu et al.

NATURE REVIEWS DRUG DISCOVERY (2009)

Review Oncology

Diagnosis and management of lipomatous tumors

Kimberly Moore Dalal et al.

JOURNAL OF SURGICAL ONCOLOGY (2008)

Article Cell Biology

Effects of RAS on the genesis of embryonal rhabdomyosarcoma

David M. Langenau et al.

GENES & DEVELOPMENT (2007)

Article Biochemistry & Molecular Biology

The AKT-mTOR pathway plays a critical role in the development of leiomyosarcomas

Eva Hernando et al.

NATURE MEDICINE (2007)

Article Oncology

Differential sensitivity of liposarcoma subtypes to chemotherapy

RL Jones et al.

EUROPEAN JOURNAL OF CANCER (2005)

Article Multidisciplinary Sciences

tp53 mutant zebrafish develop malignant peripheral nerve sheath tumors

S Berghmans et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)

Review Cell Biology

Upstream and downstream of mTOR

N Hay et al.

GENES & DEVELOPMENT (2004)